{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:44:41Z","timestamp":1777121081265,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10384-015-0421-1","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T04:54:07Z","timestamp":1454475247000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Predictive factors for ocular complications caused by anticancer drug S-1"],"prefix":"10.1007","volume":"60","author":[{"given":"Rika","family":"Yamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Hirabatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Kurimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,3]]},"reference":[{"key":"421_CR1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1023\/A:1026142601822","volume":"30","author":"E Comets","year":"2003","unstructured":"Comets E, Ikeda K, Hoff P, Fumoleau P, Wanders J, Tanigawara Y. Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients. J Pharmacokinet Pharmacodyn. 2003;30:257\u201383.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"421_CR2","first-page":"2000","volume":"5","author":"K Hirata","year":"1999","unstructured":"Hirata K, Horikoshi N, Aiba K, Okazaki M, Denno R, Sasaki K, et al. Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug. Clin Cancer Res. 1999;5:2000\u20135.","journal-title":"Clin Cancer Res"},{"key":"421_CR3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.bjc.6601224","volume":"89","author":"Y Yamada","year":"2003","unstructured":"Yamada Y, Hamaguchi T, Goto M, Muro K, Matsumura Y, Shimada Y, et al. Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil. Br J Cancer. 2003;89:816\u201320.","journal-title":"Br J Cancer"},{"key":"421_CR4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001813-199607000-00010","volume":"7","author":"T Shirasaka","year":"1996","unstructured":"Shirasaka T, Shimamato Y, Ohshimo H, Yamaguchi M, Kato T, Yonekura K, et al. Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs. 1996;7:548\u201357.","journal-title":"Anticancer Drugs"},{"key":"421_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000323286","volume":"79","author":"B Nakata","year":"2010","unstructured":"Nakata B, Tsuji A, Mitachi Y, Taenaka N, Kamano T, Oikawa K, et al. Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step 2). Oncology. 2010;79:337\u201342.","journal-title":"Oncology"},{"issue":"Suppl. 1","key":"421_CR6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10120-003-0232-9","volume":"6","author":"Y Maehara","year":"2003","unstructured":"Maehara Y. S-1 in gastric cancer: a comprehensive review. Gastric cancer. 2003;6[Suppl 1]:2\u20138.","journal-title":"Gastric cancer"},{"key":"421_CR7","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810\u201320.","journal-title":"N Engl J Med"},{"key":"421_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u201321.","journal-title":"Lancet Oncol"},{"key":"421_CR9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajo.2005.01.052","volume":"140","author":"B Esmaeli","year":"2005","unstructured":"Esmaeli B, Golio D, Lubecki L, Ajani J. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1. Am J Ophthalmol. 2005;140:325\u20137.","journal-title":"Am J Ophthalmol"},{"key":"421_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10384-012-0127-6","volume":"56","author":"T Sasaki","year":"2012","unstructured":"Sasaki T, Miyashita H, Miyanaga T, Yamamoto K, Sugiyama K. Dacryoendoscopic observation and incidence of canalicular obstruction\/stenosis associated with S-1, an oral anticancer drug. Jpn J Ophthalmol. 2012;56:214\u20138.","journal-title":"Jpn J Ophthalmol"},{"key":"421_CR11","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mds106","volume":"23","author":"N Kim","year":"2012","unstructured":"Kim N, Park C, Park DJ, Kim HH, Kim S, Kim YJ, et al. Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapy. Ann Oncol. 2012;23:2065\u201371.","journal-title":"Ann Oncol"},{"key":"421_CR12","first-page":"2896","volume":"15","author":"T Chikama","year":"2009","unstructured":"Chikama T, Takahashi N, Wakuta M, Nishida T. Noninvasive direct detection of ocular mucositis by in vivo confocal microscopy in patients treated with S-1. Mol Vis. 2009;15:2896\u2013904.","journal-title":"Mol Vis"},{"key":"421_CR13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00003226-199307000-00015","volume":"12","author":"I Toda","year":"1993","unstructured":"Toda I, Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea. 1993;12:366\u20137.","journal-title":"Cornea"},{"key":"421_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1445-5994.1979.tb04317.x","volume":"9","author":"N Christophidis","year":"1979","unstructured":"Christophidis N, Vajda FJ, Lucas I, Louis WJ. Ocular side effects with 5-fluorouracil. Aust NZ J Med. 1979;9:143\u20134.","journal-title":"Aust NZ J Med"},{"key":"421_CR15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/07357909009012068","volume":"8","author":"CL Loprinzi","year":"1990","unstructured":"Loprinzi CL, Love RR, Garrity JA, Ames MM. Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity. Cancer Investig. 1990;8:459\u201365.","journal-title":"Cancer Investig"},{"key":"421_CR16","first-page":"553","volume":"68","author":"H Toide","year":"1977","unstructured":"Toide H, Akiyoshi H, Minato Y, Okuda H, Fujii S. Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil. Gann. 1977;68:553\u201360.","journal-title":"Gann"},{"key":"421_CR17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-88-5-657_1","volume":"88","author":"DJ Haidak","year":"1978","unstructured":"Haidak DJ, Hurwitz BS, Yeung KY. Tear-duct fibrosis (dacryostenosis) due to 5-fluorouracil. Ann Intern Med. 1978;88:657.","journal-title":"Ann Intern Med"},{"issue":"Pt 3a","key":"421_CR18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/eye.1998.83","volume":"12","author":"V Lee","year":"1998","unstructured":"Lee V, Bentley CR, Olver JM. Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy. Eye. 1998;12(Pt 3a):343\u20139.","journal-title":"Eye"},{"key":"421_CR19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3928\/1542-8877-19990201-06","volume":"30","author":"JP Fezza","year":"1999","unstructured":"Fezza JP, Wesley RE, Klippenstein KA. The treatment of punctal and canalicular stenosis in patients on systemic 5-FU. Ophthalmic Surg Lasers. 1999;30:105\u20138.","journal-title":"Ophthalmic Surg Lasers"},{"key":"421_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01203288","volume":"90","author":"HM Brink","year":"1995","unstructured":"Brink HM, Beex LV. Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature. Doc Ophthalmol. 1995;90:1\u20136.","journal-title":"Doc Ophthalmol"},{"key":"421_CR21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0420.2000.078001110.x","volume":"78","author":"S Prasad","year":"2000","unstructured":"Prasad S, Kamath GG, Phillips RP. Lacrimal canalicular stenosis associated with systemic 5-fluorouacil therapy. Acta Ophthalmol Scand. 2000;78:110\u20133.","journal-title":"Acta Ophthalmol Scand"},{"key":"421_CR22","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0161-6420(02)01290-3","volume":"109","author":"MR Agarwal","year":"2002","unstructured":"Agarwal MR, Esmaeli B, Burnstine MA. Squamous metaplasia of the canaliculi associated with 5-fluorouracil: a clinicopathologic case report. Ophthalmology. 2002;109:2359\u201361.","journal-title":"Ophthalmology"},{"key":"421_CR23","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/ICO.0b013e31816f5ec3","volume":"27","author":"T Zheng","year":"2008","unstructured":"Zheng T, Xu J. Age-related changes of human limbus on in vivo confocal microscopy. Cornea. 2008;27:782\u20136.","journal-title":"Cornea"},{"key":"421_CR24","first-page":"259","volume":"38","author":"H Kitamura","year":"2011","unstructured":"Kitamura H, Miyanaga T, Shin H, Fujita M, Miyazaki M, Yagi D, et al. Investigation of epiphora following S-1 therapy. Gan To Kagaku Ryoho. 2011;38:259\u201362.","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-015-0421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-015-0421-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-015-0421-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T02:53:44Z","timestamp":1654224824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-015-0421-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,3]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1007\/s10384-015-0421-1","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,3]]}}}